Genprex (GNPX) EPS (Basic) Growth (5y) (2021 - 2025)
Genprex (GNPX) EPS (Basic) Growth (5y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - |
| 10 | Genprex | 1.88 Mn | -13.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 64.43% |
| Dec 31, 2024 | 29.50% |
| Sep 30, 2024 | 27.02% |
| Jun 30, 2024 | 20.41% |
| Mar 31, 2024 | 7.97% |
| Dec 31, 2023 | 15.41% |
| Sep 30, 2023 | 2.02% |
| Jun 30, 2023 | 19.24% |
| Mar 31, 2023 | -25.95% |
| Dec 31, 2022 | -18.65% |
| Sep 30, 2022 | 15.97% |
| Jun 30, 2022 | -2.66% |
| Mar 31, 2022 | -10.97% |
| Dec 31, 2021 | -9.21% |